Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.

[1]  M. Tötsch,et al.  The diagnostic role of BAP1 in serous effusions. , 2018, Human pathology.

[2]  S. Mukhopadhyay,et al.  Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections , 2018, Modern Pathology.

[3]  M. Dietel,et al.  A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal , 2018, Modern Pathology.

[4]  Kenji Suzuki,et al.  Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and ΔNp63/p40. , 2018, Human pathology.

[5]  L. Harris,et al.  Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma. , 2018, Human pathology.

[6]  K. Hiroshima,et al.  SMARCB1/INI1/BAF47‐ deficient pleural malignant mesothelioma with rhabdoid features , 2018, Pathology international.

[7]  Jeong Hwan Park,et al.  Clinicopathological and molecular implications of aberrant thyroid transcription factor‐1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones , 2018, Histopathology.

[8]  M. Arcila,et al.  Novel Modification of HistoGel-Based Cell Block Preparation Method: Improved Sufficiency for Molecular Studies. , 2017, Archives of pathology & laboratory medicine.

[9]  G. Berry,et al.  Primary mammary analogue secretory carcinoma of the lung: a case report. , 2017, Human pathology.

[10]  M. Ladanyi,et al.  Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: Napsin A expression and genomic alterations , 2017, Modern Pathology.

[11]  K. Nackaerts,et al.  20 – Clinical Presentation and Prognostic Factors in Lung Cancer , 2018 .

[12]  Tao Zhang,et al.  Aberrant expression of thyroid transcription factor-1 in schwannomas. , 2018, Human pathology.

[13]  A. Rajwanshi,et al.  The role of the cytopathologist in subtyping and epidermal growth factor receptor testing in non‐small cell lung cancer: An institutional experience , 2017, Cytopathology : official journal of the British Society for Clinical Cytology.

[14]  A. Churg,et al.  GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung , 2017, The American journal of surgical pathology.

[15]  F. Galateau-Sallé,et al.  The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center. , 2017, Human pathology.

[16]  P. Argani,et al.  Utility of Sox10 labeling in metastatic breast carcinomas. , 2017, Human pathology.

[17]  Lauren L. Ritterhouse,et al.  GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas , 2017, Modern Pathology.

[18]  B. Skov,et al.  Paired Comparison of PD-L1 Expression on Cytologic and Histologic Specimens From Malignancies in the Lung Assessed With PD-L1 IHC 28-8pharmDx and PD-L1 IHC 22C3pharmDx , 2017, Applied immunohistochemistry & molecular morphology : AIMM.

[19]  P. Illei,et al.  INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity , 2017, The American journal of surgical pathology.

[20]  I. van Seuningen,et al.  Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers. , 2017, Lung cancer.

[21]  Laura H. Tang,et al.  Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver , 2017, The American journal of surgical pathology.

[22]  A. Roden,et al.  SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior , 2017, Modern Pathology.

[23]  P. Stephens,et al.  Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  J. Colinge,et al.  Cell-Cycle Regulation Accounts for Variability in Ki-67 Expression Levels. , 2017, Cancer research.

[25]  C. Moran,et al.  "Sarcomatoid" carcinomas of the lung: a clinicopathological study of 86 cases with a new perspective on tumor classification. , 2017, Human pathology.

[26]  Boris Sepesi,et al.  Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature , 2017, Virchows Archiv.

[27]  T. Kohno,et al.  Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities , 2017, Modern Pathology.

[28]  A. Nicholson,et al.  The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[29]  Faqian Li,et al.  mASH1 is Highly Specific for Neuroendocrine Carcinomas: An Immunohistochemical Evaluation on Normal and Various Neoplastic Tissues. , 2017, Archives of pathology & laboratory medicine.

[30]  I. Wistuba,et al.  Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases. , 2017, Human pathology.

[31]  G. Rossi,et al.  Synchronous occurrence of squamous-cell carcinoma "transformation" and EGFR exon 20 S768I mutation as a novel mechanism of resistance in EGFR-mutated lung adenocarcinoma. , 2017, Lung cancer.

[32]  B. Ljung,et al.  Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study , 2016, Cancer cytopathology.

[33]  Yih-Leong Chang,et al.  SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma. , 2016, Human pathology.

[34]  K. Jirström,et al.  Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non–Small Cell Lung Carcinoma , 2016, Applied immunohistochemistry & molecular morphology : AIMM.

[35]  Yufeng Shen,et al.  Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  A. Moreira,et al.  Lung Carcinoma Predictive Biomarker Testing by Immunoperoxidase Stains in Cytology and Small Biopsy Specimens: Advantages and Limitations. , 2016, Archives of pathology & laboratory medicine.

[37]  Tsung-Teh Wu,et al.  Arginase-1 is frequently positive in hepatoid adenocarcinomas. , 2016, Human pathology.

[38]  Anjali Saqi,et al.  The State of Cell Blocks and Ancillary Testing: Past, Present, and Future. , 2016, Archives of pathology & laboratory medicine.

[39]  A. Gown,et al.  BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas , 2016, The American journal of surgical pathology.

[40]  G. Rossi,et al.  Squamous Cell Carcinoma "Transformation" Concurrent with Secondary T790M Mutation in Resistant EGFR-Mutated Adenocarcinomas. , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[41]  Philippe Jay,et al.  The cell proliferation antigen Ki-67 organises heterochromatin , 2016, eLife.

[42]  M. Henry,et al.  Young investigator challenge: Validation and optimization of immunohistochemistry protocols for use on cellient cell block specimens , 2016, Cancer cytopathology.

[43]  A. Nicholson,et al.  Testing for Neuroendocrine Immunohistochemical Markers Should Not Be Performed in Poorly Differentiated NSCCs in the Absence of Neuroendocrine Morphologic Features according to the 2015 WHO Classification. , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[44]  Hao-dong Xu,et al.  hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors. , 2016, Human pathology.

[45]  C. Moran,et al.  Primary Pulmonary Salivary Gland-type Tumors: A Review and Update , 2016, Advances in anatomic pathology.

[46]  Y. Jeng,et al.  The Diagnostic Utility of PAX8 for Neuroendocrine Tumors: An Immunohistochemical Reappraisal , 2016, Applied immunohistochemistry & molecular morphology : AIMM.

[47]  C. Antonescu,et al.  Thoracic Myoepithelial Tumors: A Pathologic and Molecular Study of 8 Cases With Review of the Literature , 2015, The American journal of surgical pathology.

[48]  M. Kriegsmann,et al.  Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: A large scale study of 1465 non-small cell lung cancer cases , 2015, Diagnostic Pathology.

[49]  U. Pastorino,et al.  Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic–Phenotypic Correlations to Emerge , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[50]  R. Marks,et al.  Histopathologic and Cytogenetic Features of Pulmonary Adenoid Cystic Carcinoma , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[51]  M. Aubry,et al.  Detection of human papillomavirus in non-small cell carcinoma of the lung. , 2015, Human pathology.

[52]  Liang Cheng,et al.  Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma , 2015, Applied immunohistochemistry & molecular morphology : AIMM.

[53]  H. Popper,et al.  Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival , 2015, Virchows Archiv.

[54]  U. Pastorino,et al.  Challenging Lung Carcinoma with Coexistent ΔNp63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[55]  R. Lloyd,et al.  INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms. , 2015, American journal of clinical pathology.

[56]  N. Girard,et al.  SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas , 2015, Nature Genetics.

[57]  David R. Jones,et al.  Reevaluation and Reclassification of Resected Lung Carcinomas Originally Diagnosed as Squamous Cell Carcinoma Using Immunohistochemical Analysis , 2015, The American journal of surgical pathology.

[58]  J. Austin,et al.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[59]  D. Henderson,et al.  An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma* , 2015, Journal of Clinical Pathology.

[60]  A. Vink,et al.  Different Cutoff Values for Thyroid Transcription Factor-1 Antibodies in the Diagnosis of Lung Adenocarcinoma , 2015, Applied immunohistochemistry & molecular morphology : AIMM.

[61]  Y. Nakatani,et al.  Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium. , 2015, Human pathology.

[62]  C. Antonescu,et al.  Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement , 2015, The American journal of surgical pathology.

[63]  M. Mino‐Kenudson,et al.  Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[64]  Masahide Takahashi,et al.  Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung , 2015, Pathology international.

[65]  F. Askin,et al.  Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases , 2015, Clinical and Translational Medicine.

[66]  D. Creytens,et al.  Multifocal cytokeratin expression in pleural and abdominal malignant solitary fibrous tumors: an unusual diagnostic pitfall , 2015, Virchows Archiv.

[67]  P. Barnes,et al.  CytoLyt® Fixation and Decalcification Pretreatments Alter Antigenicity in Normal Tissues Compared With Standard Formalin Fixation , 2015, Applied immunohistochemistry & molecular morphology : AIMM.

[68]  N. Rekhtman,et al.  Nonspecific reactivity of polyclonal napsin a antibody in mucinous adenocarcinomas of various sites: a word of caution. , 2015, Archives of pathology & laboratory medicine.

[69]  Shawn B. Jackson,et al.  Primary pulmonary hyalinizing clear cell carcinoma of bronchial submucosal gland origin. , 2015, Human pathology.

[70]  Weiya Wang,et al.  Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non‐small cell lung cancer: A comparison of Ventana immunohistochemistry and fluorescence in situ hybridization , 2015, Cancer cytopathology.

[71]  Parvez M Lokhandwala,et al.  Mitotic Count by Phosphohistone H3 Immunohistochemical Staining Predicts Survival and Improves Interobserver Reproducibility in Well-differentiated Neuroendocrine Tumors of the Pancreas , 2015, The American journal of surgical pathology.

[72]  W. Travis.  WHO classification of tumours of the lung, pleura, thymus and heart , 2015 .

[73]  J. Hunt,et al.  Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors. , 2015, Archives of pathology & laboratory medicine.

[74]  Y. Jeon,et al.  A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non‐small cell lung cancers , 2014, Histopathology.

[75]  V. Iyer,et al.  Cell blocks in cytopathology: a review of preparative methods, utility in diagnosis and role in ancillary studies , 2014, Cytopathology : official journal of the British Society for Clinical Cytology.

[76]  A. Agaimy.  The Expanding Family of SMARCB1(INI1)-deficient Neoplasia: Implications of Phenotypic, Biological, and Molecular Heterogeneity , 2014, Advances in anatomic pathology.

[77]  K. Tsuta,et al.  Utility of PAX8 mouse monoclonal antibody in the diagnosis of thyroid, thymic, pleural and lung tumours: a comparison with polyclonal PAX8 antibody , 2014, Histopathology.

[78]  Xiao-yan Xu,et al.  Analysis of clinical characteristics and differential diagnosis of the lung biopsy specimens in 99 adenocarcinoma cases and 111 squamous cell carcinoma cases: utility of an immunohistochemical panel containing CK5/6, CK34βE12, p63, CK7 and TTF-1. , 2014, Pathology, research and practice.

[79]  Dafydd G. Thomas,et al.  Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors. , 2014, American journal of clinical pathology.

[80]  C. Sima,et al.  Comprehensive Pathological Analyses in Lung Squamous Cell Carcinoma: Single Cell Invasion, Nuclear Diameter, and Tumor Budding Are Independent Prognostic Factors for Worse Outcomes , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[81]  J. Heymann,et al.  Polyclonal napsin A expression: a potential diagnostic pitfall in distinguishing primary from metastatic mucinous tumors in the lung. , 2014, Archives of pathology & laboratory medicine.

[82]  B. Delahunt,et al.  Immunohistochemical profile of ductal adenocarcinoma of the prostate , 2014, Virchows Archiv.

[83]  Dachuan Zhang,et al.  ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens. , 2014, International journal of clinical and experimental pathology.

[84]  F. Khuri,et al.  HPV-associated lung cancers: an international pooled analysis. , 2014, Carcinogenesis.

[85]  P. Stephens,et al.  Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. , 2014, Cancer discovery.

[86]  A. Fischer,et al.  Immunohistochemistry practices of cytopathology laboratories: a survey of participants in the College of American Pathologists Nongynecologic Cytopathology Education Program. , 2014, Archives of pathology & laboratory medicine.

[87]  J. L. Bruce,et al.  Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma. , 2014, Archives of pathology & laboratory medicine.

[88]  T. Colby,et al.  Histopathologic, immunophenotypic and cytogenetic features of pulmonary mucoepidermoid carcinoma , 2014, Modern Pathology.

[89]  H. Asamura,et al.  STAT6 Immunohistochemistry Is Helpful in the Diagnosis of Solitary Fibrous Tumors , 2014, The American journal of surgical pathology.

[90]  M. Bousamra,et al.  Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature , 2014, Modern Pathology.

[91]  J. Heymann,et al.  The state of cell block variation and satisfaction in the era of molecular diagnostics and personalized medicine , 2014, CytoJournal.

[92]  G. Pelosi,et al.  Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas , 2014, International journal of surgical pathology.

[93]  G. Tse,et al.  TTF‐1 expression in breast carcinoma: an unusual but real phenomenon , 2014, Histopathology.

[94]  K. Bensalah,et al.  BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma. , 2014, The Journal of urology.

[95]  W. Travis,et al.  Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical Practice , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[96]  T. Chou,et al.  Pulmonary neuroendocrine tumors: Study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses , 2014, Journal of surgical oncology.

[97]  F. Mertens,et al.  Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics , 2014, Modern Pathology.

[98]  K. Kashima,et al.  Significant Expression of Thyroid Transcription Factor-1 in Pulmonary Squamous Cell Carcinoma Detected by SPT24 Monoclonal Antibody and CSA-II System , 2014, Applied immunohistochemistry & molecular morphology : AIMM.

[99]  A. Krasinskas,et al.  KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas , 2014, Modern Pathology.

[100]  Markku Miettinen,et al.  GATA3: A Multispecific But Potentially Useful Marker in Surgical Pathology A Systematic Analysis of 2500 Epithelial and Nonepithelial Tumors , 2014, The American journal of surgical pathology.

[101]  R. Henrique,et al.  A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens , 2013, Virchows Archiv.

[102]  L. Bubendorf,et al.  Detection of ALK-Positive Non–Small-Cell Lung Cancers on Cytological Specimens: High Accuracy of Immunocytochemistry with the 5A4 Clone , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[103]  L. Chirieac,et al.  p16 Deletion in sarcomatoid tumors of the lung and pleura. , 2013, Archives of pathology & laboratory medicine.

[104]  D. Ettinger,et al.  Utility of the Quantitative Ki-67 Proliferation Index and CD56 Together in the Cytologic Diagnosis of Small Cell Lung Carcinoma and Other Lung Neuroendocrine Tumors , 2013, Acta Cytologica.

[105]  J. Bishop.  Unmasking MASC: Bringing to Light the Unique Morphologic, Immunohistochemical and Genetic Features of the Newly Recognized Mammary Analogue Secretory Carcinoma of Salivary Glands , 2013, Head and Neck Pathology.

[106]  Zhong Jiang,et al.  Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study. , 2013, American journal of clinical pathology.

[107]  Y. Yatabe,et al.  HNF4&agr; as a Marker for Invasive Mucinous Adenocarcinoma of the Lung , 2013, The American journal of surgical pathology.

[108]  M. Ladanyi,et al.  Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. , 2013, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[109]  G. Pelosi,et al.  Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology , 2013, Virchows Archiv.

[110]  Wilko Weichert,et al.  Large‐scale comparative analyses of immunomarkers for diagnostic subtyping of non‐small‐cell lung cancer biopsies , 2012, Histopathology.

[111]  S. Mukhopadhyay,et al.  Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas. , 2012, American journal of clinical pathology.

[112]  D. Arenberg,et al.  The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma , 2012, Diagnostic cytopathology.

[113]  J. McKenney,et al.  Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. , 2012, Archives of pathology & laboratory medicine.

[114]  J. Lunceford,et al.  Level of phosphohistone H3 among various types of human cancers , 2012, BMJ Open.

[115]  J. Epstein,et al.  Utility of GATA3 Immunohistochemistry in Differentiating Urothelial Carcinoma From Prostate Adenocarcinoma and Squamous Cell Carcinomas of the Uterine Cervix, Anus, and Lung , 2012, The American journal of surgical pathology.

[116]  N. Ordóñez,et al.  Value of Thyroid Transcription Factor-1 Immunostaining in Tumor Diagnosis: A Review and Update , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[117]  D. Jackman,et al.  Pathologic Characteristics of NUT Midline Carcinoma Arising in the Mediastinum , 2012, The American journal of surgical pathology.

[118]  H. Kimbrell,et al.  Subclassification of Non-Small Cell Lung Cancer by Cytologic Sampling: A Logical Approach with Selective Use of Immunocytochemistry , 2012, Acta Cytologica.

[119]  D. Nonaka.  A Study of &Dgr;Np63 Expression in Lung Non-Small Cell Carcinomas , 2012, The American journal of surgical pathology.

[120]  M. Schwartz,et al.  Comparison of Breast Carcinoma Prognostic/Predictive Biomarkers on Cell Blocks Obtained by Various Methods: Cellient, Formalin and Thrombin , 2012, Acta Cytologica.

[121]  Prasad S Adusumilli,et al.  A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma , 2012, Modern Pathology.

[122]  Songmi Noh,et al.  Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas. , 2012, Lung cancer.

[123]  Giuseppe Pelosi,et al.  p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma , 2012, Modern Pathology.

[124]  P. Cagle,et al.  Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. , 2012, Archives of pathology & laboratory medicine.

[125]  J. Jagirdar,et al.  Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. , 2012, Archives of pathology & laboratory medicine.

[126]  P. Illei,et al.  HPV Analysis in Distinguishing Second Primary Tumors From Lung Metastases in Patients With Head and Neck Squamous Cell Carcinoma , 2012, The American journal of surgical pathology.

[127]  N. Ordóñez.  Napsin A expression in lung and kidney neoplasia: a review and update. , 2012, Advances in anatomic pathology.

[128]  P. Chu,et al.  Determining the Site of Origin of Mucinous Adenocarcinoma: An Immunohistochemical Study of 175 Cases , 2011, The American journal of surgical pathology.

[129]  L. Lino-Silva,et al.  TLE1 is expressed in the majority of primary pleuropulmonary synovial sarcomas , 2011, Virchows Archiv.

[130]  F. Schmitt,et al.  Immunocytochemistry in Europe: results of the European Federation of Cytology Societies (EFCS) inquiry , 2011, Cytopathology : official journal of the British Society for Clinical Cytology.

[131]  K. Miller,et al.  External quality control for immunocytochemistry on cytology samples: a review of UK NEQAS ICC (cytology module) results , 2011, Cytopathology : official journal of the British Society for Clinical Cytology.

[132]  I. Wistuba,et al.  Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas. , 2011, American journal of clinical pathology.

[133]  T. Kohno,et al.  Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas , 2011, The American journal of surgical pathology.

[134]  Mattia Barbareschi,et al.  Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine‐needle aspiration cytology , 2011, Cancer.

[135]  Y. Yatabe,et al.  Thyroid transcription factor‐1 expression in rare cases of mammary ductal carcinoma , 2011, Histopathology.

[136]  A. Folpe,et al.  BCL-6 expression in mesenchymal tumours: an immunohistochemical and fluorescence in situ hybridisation study , 2011, Journal of Clinical Pathology.

[137]  S. Dacic,et al.  Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens. , 2011, American journal of clinical pathology.

[138]  M. Loda,et al.  A Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors , 2011, The American journal of surgical pathology.

[139]  C. Sima,et al.  Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens , 2011, Modern Pathology.

[140]  T. Kodama,et al.  The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor‐1 (TTF‐1)‐negative pulmonary adenocarcinoma , 2011, Histopathology.

[141]  Sanjay Mukhopadhyay,et al.  Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens: Utility of an Immunohistochemical Panel Containing TTF-1, Napsin A, p63, and CK5/6 , 2011, The American journal of surgical pathology.

[142]  Z. Maleki.  Diagnostic issues with cytopathologic interpretation of lung neoplasms displaying high‐grade basaloid or neuroendocrine morphology , 2010, Diagnostic cytopathology.

[143]  D. Clark,et al.  The utility of napsin‐A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas , 2010, Cancer cytopathology.

[144]  L. Goldstein,et al.  Thyroid Transcription Factor-1 Expression in Breast Carcinomas , 2010, The American journal of surgical pathology.

[145]  W. Travis.  Sarcomatoid neoplasms of the lung and pleura. , 2010, Archives of pathology & laboratory medicine.

[146]  E. Nakakura,et al.  Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site. , 2010, The Journal of surgical research.

[147]  E. Montgomery,et al.  NKX3.1 as a Marker of Prostatic Origin in Metastatic Tumors , 2010, The American journal of surgical pathology.

[148]  M. Antoine,et al.  Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib. , 2010, Lung cancer.

[149]  Y. Yatabe,et al.  Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor. , 2010, Human pathology.

[150]  D. Nonaka,et al.  A study of immunohistochemical differential expression in pulmonary and mammary carcinomas , 2010, Modern Pathology.

[151]  I. Wistuba,et al.  Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation , 2009, Clinical Cancer Research.

[152]  M. Fiegl,et al.  Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases , 2009, Virchows Archiv.

[153]  M. Rubin,et al.  Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody , 2009, The American journal of surgical pathology.

[154]  A. Nicholson,et al.  Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. , 2009, Human pathology.

[155]  Amitabh Srivastava,et al.  Immunohistochemical Staining for CDX-2, PDX-1, NESP-55, and TTF-1 Can Help Distinguish Gastrointestinal Carcinoid Tumors From Pancreatic Endocrine and Pulmonary Carcinoid Tumors , 2009, The American journal of surgical pathology.

[156]  I. Petersen,et al.  Molecular HPV Typing as a Diagnostic Tool to Discriminate Primary From Metastatic Squamous Cell Carcinoma of the Lung , 2009, The American journal of surgical pathology.

[157]  S. Suster,et al.  Pulmonary epithelial-myoepithelial carcinoma: a clinicopathologic and immunohistochemical study of 5 cases. , 2009, Human pathology.

[158]  V. Livolsi,et al.  TTF-1 Expression in Ovarian and Uterine Epithelial Neoplasia and its Potential Significance, an Immunohistochemical Assessment With Multiple Monoclonal Antibodies and Different Secondary Detection Systems , 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[159]  R. Hehlmann,et al.  Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions , 2008, Cytopathology : official journal of the British Society for Clinical Cytology.

[160]  S. Dacic,et al.  Gross Cystic Disease Fluid Protein—(GCDFP-15): Expression in Primary Lung Adenocarcinoma , 2008, The American journal of surgical pathology.

[161]  H. Asamura,et al.  Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. , 2008, Archives of pathology & laboratory medicine.

[162]  A. Gazdar,et al.  Lung cancer in never smokers — a different disease , 2007, Nature Reviews Cancer.

[163]  Heather N Watson,et al.  Histologic features are important prognostic indicators in early stages lung adenocarcinomas , 2007, Modern Pathology.

[164]  H. Iwata,et al.  Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers , 2007, Modern Pathology.

[165]  R. Wood‐Baker,et al.  Nonsmall Cell Lung Carcinoma With Neuroendocrine Differentiation—An Entity of No Clinical or Prognostic Significance , 2007, The American journal of surgical pathology.

[166]  D. Dabbs,et al.  Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. , 2007, American journal of clinical pathology.

[167]  D. Zander,et al.  TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material , 2006, Modern Pathology.

[168]  Takehiko Fujisawa,et al.  Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis , 2006, Modern Pathology.

[169]  A. Ochiai,et al.  Comparison of the immunophenotypes of signet‐ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin , 2006, The Journal of pathology.

[170]  V. Capelozzi,et al.  Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas. , 2006, Human pathology.

[171]  S. Abe,et al.  Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs. , 2005, Pathology, research and practice.

[172]  R. Tsuchiya,et al.  Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. , 2005, Chest.

[173]  A. Borczuk,et al.  CDX2 Immunostaining as a Gastrointestinal Marker: Expression in Lung Carcinomas Is a Potential Pitfall , 2005, Applied immunohistochemistry & molecular morphology : AIMM.

[174]  K. Kerr,et al.  Neuroendocrine differentiation in non‐small cell lung cancer and its relation to prognosis and therapy , 2005, Histopathology.

[175]  J. Lafitte,et al.  Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis , 2004, British Journal of Cancer.

[176]  C. Antonescu,et al.  Midline carcinoma of children and young adults with NUT rearrangement. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[177]  L. Johansson.  Histopathologic classification of lung cancer: Relevance of cytokeratin and TTF-1 immunophenotyping. , 2004, Annals of diagnostic pathology.

[178]  J. Silverman,et al.  Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma. , 2004, American journal of clinical pathology.

[179]  C. Fisher,et al.  Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature , 2004, Modern Pathology.

[180]  Y. Yatabe,et al.  CK20 expression, CDX2 expression, K‐ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas , 2004, The Journal of pathology.

[181]  E. Brambilla,et al.  Primary Mucinous (So-called Colloid) Carcinomas of the Lung: A Clinicopathologic and Immunohistochemical Study With Special Reference to CDX-2 Homeobox Gene and MUC2 Expression , 2004, The American journal of surgical pathology.

[182]  K. Kerr,et al.  Thyroid transcription factor 1 in pulmonary adenocarcinoma , 2004, Journal of Clinical Pathology.

[183]  A. Moreira,et al.  Differential Expression of Cytokeratins 7 and 20 and Thyroid Transcription Factor-1 in Bronchioloalveolar Carcinoma , 2004 .

[184]  A. Moreira,et al.  Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens. , 2004, American journal of clinical pathology.

[185]  H. Asamura,et al.  hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors , 2004, Modern Pathology.

[186]  G. Elmberger,et al.  Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma , 2003, British Journal of Cancer.

[187]  M. Ladanyi,et al.  The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions , 2002, Cancer.

[188]  M. Sheppard,et al.  Small Cell Lung Carcinoma (SCLC): A Clinicopathologic Study of 100 Cases With Surgical Specimens , 2002, The American journal of surgical pathology.

[189]  S. Lau,et al.  Thyroid Transcription Factor-1: A Review , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[190]  S. Lau,et al.  Expression of Thyroid Transcription Factor-1, Cytokeratin 7, and Cytokeratin 20 in Bronchioloalveolar Carcinomas: an Immunohistochemical Evaluation of 67 Cases , 2002, Modern Pathology.

[191]  P. Tamboli,et al.  Primary Signet-Ring Cell Carcinoma of Lung: Immunohistochemical Study and Comparison With Non-Pulmonary Signet-Ring Cell Carcinomas , 2001, The American journal of surgical pathology.

[192]  S. Suster,et al.  Primary signet ring cell adenocarcinomas of the lung: a clinicopathological study of 15 cases , 2001, Histopathology.

[193]  N. Goldstein,et al.  Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. , 2001, American journal of clinical pathology.

[194]  L. Weiss,et al.  Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. , 2000, Human pathology.

[195]  S. Baylin,et al.  Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice. , 2000, Cancer research.

[196]  A. Huvos,et al.  Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients. , 2000, The American journal of surgical pathology.

[197]  A. Folpe,et al.  Thyroid Transcription Factor-1 Is Expressed in Extrapulmonary Small Cell Carcinomas but Not in Other Extrapulmonary Neuroendocrine Tumors , 2000, Modern Pathology.

[198]  T. H. van der Kwast,et al.  The gene for the cyclin‐dependent‐kinase‐4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma , 1998, International journal of cancer.

[199]  S. Baylin,et al.  An achaete-scute homologue essential for neuroendocrine differentiation in the lung , 1997, Nature.

[200]  M. Miettinen,et al.  Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. , 1995, Human pathology.

[201]  J. Quesenberry,et al.  Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations. , 1995, The American journal of surgical pathology.

[202]  M. Fukayama,et al.  CD5 expression in thymic carcinoma. , 1994, The American journal of pathology.

[203]  S. Schnitt,et al.  SAMPLING GROSSLY BENIGN BREAST BIOPSY SPECIMENS , 1989, The Lancet.

[204]  G. Chejfec,et al.  Synaptophysin: A New Marker for Pancreatic Neuroendocrine Tumors , 1987, The American journal of surgical pathology.

[205]  R. Fechner,et al.  Acinic cell tumor of the lung. A histologic and ultrastructural study , 1972, Cancer.

[206]  M. B. Rosenblatt,et al.  Primary and metastatic bronciolo-alveolar carcinoma. , 1967, Diseases of the chest.